APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceuticals for Psoriasis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biopharmaceuticals for Psoriasis Industry Growth and Trends Forecast to 2032

28 December 202594 pages

Choose your research edition.

Industry ResearchBiopharmaceuticals for Psoriasis Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceuticals for Psoriasis Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Biopharmaceuticals for Psoriasis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceuticals for Psoriasis Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceuticals for Psoriasis Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Biopharmaceuticals for Psoriasis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biopharmaceuticals for Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biopharmaceuticals for Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceuticals for Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biopharmaceuticals for Psoriasis include Johnson & Johnson, Eli Lilly, Pfizer, AbbVie, UCB, Organon and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biopharmaceuticals for Psoriasis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biopharmaceuticals for Psoriasis market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biopharmaceuticals for Psoriasis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biopharmaceuticals for Psoriasis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biopharmaceuticals for Psoriasis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biopharmaceuticals for Psoriasis Market by Company

Johnson & Johnson

Eli Lilly

Pfizer

AbbVie

UCB

Organon

Amgen

Biopharmaceuticals for Psoriasis Segment by Type

TNF-α

Interleukin-17

Interleukin-23

Other

Biopharmaceuticals for Psoriasis Segment by Application

Hospital

Clinic

Other

Biopharmaceuticals for Psoriasis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals for Psoriasis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals for Psoriasis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals for Psoriasis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biopharmaceuticals for Psoriasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biopharmaceuticals for Psoriasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of TNF-α Table 2. Major Company of Interleukin-17 Table 3. Major Company of Interleukin-23 Table 4. Major Company of Other Table 5. Global Biopharmaceuticals for Psoriasis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (K Units) Table 7. Global Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Type (2021-2026) Table 8. Global Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 9. Global Biopharmaceuticals for Psoriasis Sales Market Share in Value by Type (2021-2026) Table 10. Global Biopharmaceuticals for Psoriasis Price by Type (2021-2026) & (US$/Unit) Table 11. Global Biopharmaceuticals for Psoriasis Sales by Type (2027-2032) & (K Units) Table 12. Global Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Type (2027-2032) Table 13. Global Biopharmaceuticals for Psoriasis Sales by Type (2027-2032) & (US$ Million) Table 14. Global Biopharmaceuticals for Psoriasis Sales Market Share in Value by Type (2027-2032) Table 15. Global Biopharmaceuticals for Psoriasis Price by Type (2027-2032) & (US$/Unit) Table 16. North America Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (K Units) Table 17. North America Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (K Units) Table 19. Europe Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (K Units) Table 23. Latin America Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 26. Biopharmaceuticals for Psoriasis Industry Trends Table 27. Biopharmaceuticals for Psoriasis Industry Drivers Table 28. Biopharmaceuticals for Psoriasis Industry Opportunities and Challenges Table 29. Biopharmaceuticals for Psoriasis Industry Restraints Table 30. Global Biopharmaceuticals for Psoriasis Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Biopharmaceuticals for Psoriasis Revenue Market Share by Company (2021-2026) Table 32. Global Biopharmaceuticals for Psoriasis Sales by Company (2021-2026) & (K Units) Table 33. Global Biopharmaceuticals for Psoriasis Sales Share by Company (2021-2026) Table 34. Global Biopharmaceuticals for Psoriasis Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Biopharmaceuticals for Psoriasis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Biopharmaceuticals for Psoriasis Major Company Production Sites and Headquarters Table 37. Global Biopharmaceuticals for Psoriasis Company, Product Type & Application Table 38. Global Biopharmaceuticals for Psoriasis Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Biopharmaceuticals for Psoriasis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Biopharmaceuticals for Psoriasis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Biopharmaceuticals for Psoriasis Sales by Region (2021-2026) & (K Units) Table 43. Global Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Region (2021-2026) Table 44. Global Biopharmaceuticals for Psoriasis Sales by Region (2021-2026) & (US$ Million) Table 45. Global Biopharmaceuticals for Psoriasis Sales Market Share in Value by Region (2021-2026) Table 46. Global Biopharmaceuticals for Psoriasis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Biopharmaceuticals for Psoriasis Sales by Region (2027-2032) & (K Units) Table 48. Global Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Region (2027-2032) Table 49. Global Biopharmaceuticals for Psoriasis Sales by Region (2027-2032) & (US$ Million) Table 50. Global Biopharmaceuticals for Psoriasis Sales Market Share in Value by Region (2027-2032) Table 51. Global Biopharmaceuticals for Psoriasis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Biopharmaceuticals for Psoriasis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (K Units) Table 54. Global Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Application (2021-2026) Table 55. Global Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 56. Global Biopharmaceuticals for Psoriasis Sales Market Share in Value by Application (2021-2026) Table 57. Global Biopharmaceuticals for Psoriasis Price by Application (2021-2026) & (US$/Unit) Table 58. Global Biopharmaceuticals for Psoriasis Sales by Application (2027-2032) & (K Units) Table 59. Global Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Application (2027-2032) Table 60. Global Biopharmaceuticals for Psoriasis Sales by Application (2027-2032) & (US$ Million) Table 61. Global Biopharmaceuticals for Psoriasis Sales Market Share in Value by Application (2027-2032) Table 62. Global Biopharmaceuticals for Psoriasis Price by Application (2027-2032) & (US$/Unit) Table 63. North America Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (K Units) Table 64. North America Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (K Units) Table 66. Europe Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (K Units) Table 70. Latin America Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Biopharmaceuticals for Psoriasis Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Eli Lilly Company Information Table 79. Eli Lilly Business Overview Table 80. Eli Lilly Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Eli Lilly Biopharmaceuticals for Psoriasis Product Portfolio Table 82. Eli Lilly Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Biopharmaceuticals for Psoriasis Product Portfolio Table 87. Pfizer Recent Development Table 88. AbbVie Company Information Table 89. AbbVie Business Overview Table 90. AbbVie Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AbbVie Biopharmaceuticals for Psoriasis Product Portfolio Table 92. AbbVie Recent Development Table 93. UCB Company Information Table 94. UCB Business Overview Table 95. UCB Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. UCB Biopharmaceuticals for Psoriasis Product Portfolio Table 97. UCB Recent Development Table 98. Organon Company Information Table 99. Organon Business Overview Table 100. Organon Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Organon Biopharmaceuticals for Psoriasis Product Portfolio Table 102. Organon Recent Development Table 103. Amgen Company Information Table 104. Amgen Business Overview Table 105. Amgen Biopharmaceuticals for Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Amgen Biopharmaceuticals for Psoriasis Product Portfolio Table 107. Amgen Recent Development Table 108. North America Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. North America Biopharmaceuticals for Psoriasis Sales by Country (2021-2026) & (K Units) Table 110. North America Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021-2026) Table 111. North America Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 112. North America Biopharmaceuticals for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 113. North America Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Biopharmaceuticals for Psoriasis Market Share by Country (2021-2026) Table 116. North America Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Biopharmaceuticals for Psoriasis Market Share Forecast by Country (2027-2032) Table 118. Europe Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Europe Biopharmaceuticals for Psoriasis Sales by Country (2021-2026) & (K Units) Table 120. Europe Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021-2026) Table 121. Europe Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 122. Europe Biopharmaceuticals for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Biopharmaceuticals for Psoriasis Market Share by Country (2021-2026) Table 126. Europe Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Biopharmaceuticals for Psoriasis Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Biopharmaceuticals for Psoriasis Sales by Country (2021-2026) & (K Units) Table 130. Asia-Pacific Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 132. Asia-Pacific Biopharmaceuticals for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Biopharmaceuticals for Psoriasis Market Share by Country (2021-2026) Table 136. Asia-Pacific Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Biopharmaceuticals for Psoriasis Market Share Forecast by Country (2027-2032) Table 138. Latin America Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Latin America Biopharmaceuticals for Psoriasis Sales by Country (2021-2026) & (K Units) Table 140. Latin America Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021-2026) Table 141. Latin America Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 142. Latin America Biopharmaceuticals for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Biopharmaceuticals for Psoriasis Market Share by Country (2021-2026) Table 146. Latin America Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Biopharmaceuticals for Psoriasis Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country (2021-2026) & (K Units) Table 150. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 152. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Biopharmaceuticals for Psoriasis Market Share by Country (2021-2026) Table 156. Middle East and Africa Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Biopharmaceuticals for Psoriasis Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Biopharmaceuticals for Psoriasis Distributors List Table 161. Biopharmaceuticals for Psoriasis Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Biopharmaceuticals for Psoriasis Image Figure 2. Global Biopharmaceuticals for Psoriasis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceuticals for Psoriasis Market Size (2021-2032) & (US$ Million) Figure 4. Global Biopharmaceuticals for Psoriasis Sales (2021-2032) & (K Units) Figure 5. TNF-α Image Figure 6. Global TNF-α Sales YoY Growth (2021-2032) & (K Units) Figure 7. Interleukin-17 Image Figure 8. Global Interleukin-17 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Interleukin-23 Image Figure 10. Global Interleukin-23 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Biopharmaceuticals for Psoriasis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Biopharmaceuticals for Psoriasis Market Share by Type 2025 VS 2032 Figure 15. North America Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 16. North America Biopharmaceuticals for Psoriasis Sales Market Share in Value by Type in 2025 Figure 17. Europe Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 18. Europe Biopharmaceuticals for Psoriasis Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Biopharmaceuticals for Psoriasis Sales Market Share in Value by Type in 2025 Figure 21. Latin America Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Biopharmaceuticals for Psoriasis Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Biopharmaceuticals for Psoriasis Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Biopharmaceuticals for Psoriasis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Biopharmaceuticals for Psoriasis Market Share by Application 2025 VS 2032 Figure 35. North America Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 36. North America Biopharmaceuticals for Psoriasis Sales Market Share in Value by Application in 2025 Figure 37. Europe Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 38. Europe Biopharmaceuticals for Psoriasis Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Biopharmaceuticals for Psoriasis Sales Market Share in Value by Application in 2025 Figure 41. Latin America Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Biopharmaceuticals for Psoriasis Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Market Share in Value by Application in 2025 Figure 45. North America Biopharmaceuticals for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Biopharmaceuticals for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Biopharmaceuticals for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Biopharmaceuticals for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Biopharmaceuticals for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Biopharmaceuticals for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Biopharmaceuticals for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Biopharmaceuticals for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Biopharmaceuticals for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Biopharmaceuticals for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Biopharmaceuticals for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Biopharmaceuticals for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Biopharmaceuticals for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Biopharmaceuticals for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Biopharmaceuticals for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Biopharmaceuticals for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Biopharmaceuticals for Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Biopharmaceuticals for Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Biopharmaceuticals for Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Biopharmaceuticals for Psoriasis Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Biopharmaceuticals for Psoriasis Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • TNF-α
  • Interleukin-17
  • Interleukin-23
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Johnson & Johnson
  • Eli Lilly
  • Pfizer
  • AbbVie
  • UCB
  • Organon
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biopharmaceuticals for Psoriasis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biopharmaceuticals for Psoriasis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biopharmaceuticals for Psoriasis Market by Type
  6. 1.3.1 TNF-α
  7. 1.3.2 Interleukin-17
  8. 1.3.3 Interleukin-23
  9. 1.3.4 Other
  10. 1.4 Global Biopharmaceuticals for Psoriasis Market Size by Type
  11. 1.4.1 Global Biopharmaceuticals for Psoriasis Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Biopharmaceuticals for Psoriasis Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Biopharmaceuticals for Psoriasis Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Biopharmaceuticals for Psoriasis Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Biopharmaceuticals for Psoriasis Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Biopharmaceuticals for Psoriasis Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Biopharmaceuticals for Psoriasis Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Biopharmaceuticals for Psoriasis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biopharmaceuticals for Psoriasis Industry Trends
  2. 2.2 Biopharmaceuticals for Psoriasis Industry Drivers
  3. 2.3 Biopharmaceuticals for Psoriasis Industry Opportunities and Challenges
  4. 2.4 Biopharmaceuticals for Psoriasis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biopharmaceuticals for Psoriasis Revenue (2021-2026)
  2. 3.2 Global Top Players by Biopharmaceuticals for Psoriasis Sales (2021-2026)
  3. 3.3 Global Top Players by Biopharmaceuticals for Psoriasis Price (2021-2026)
  4. 3.4 Global Biopharmaceuticals for Psoriasis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biopharmaceuticals for Psoriasis Major Company Production Sites & Headquarters
  6. 3.6 Global Biopharmaceuticals for Psoriasis Company, Product Type & Application
  7. 3.7 Global Biopharmaceuticals for Psoriasis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biopharmaceuticals for Psoriasis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biopharmaceuticals for Psoriasis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biopharmaceuticals for Psoriasis Tier 1, Tier 2, and Tier 3
4 Biopharmaceuticals for Psoriasis Regional Status and Outlook
  1. 4.1 Global Biopharmaceuticals for Psoriasis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biopharmaceuticals for Psoriasis Historic Market Size by Region
  3. 4.2.1 Global Biopharmaceuticals for Psoriasis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biopharmaceuticals for Psoriasis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biopharmaceuticals for Psoriasis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biopharmaceuticals for Psoriasis Forecasted Market Size by Region
  7. 4.3.1 Global Biopharmaceuticals for Psoriasis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biopharmaceuticals for Psoriasis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biopharmaceuticals for Psoriasis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biopharmaceuticals for Psoriasis by Application
  1. 5.1 Biopharmaceuticals for Psoriasis Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Biopharmaceuticals for Psoriasis Market Size by Application
  6. 5.2.1 Global Biopharmaceuticals for Psoriasis Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Biopharmaceuticals for Psoriasis Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Biopharmaceuticals for Psoriasis Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Biopharmaceuticals for Psoriasis Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Biopharmaceuticals for Psoriasis Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Biopharmaceuticals for Psoriasis Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Biopharmaceuticals for Psoriasis Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Biopharmaceuticals for Psoriasis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Biopharmaceuticals for Psoriasis Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Biopharmaceuticals for Psoriasis Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Biopharmaceuticals for Psoriasis Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AbbVie Biopharmaceuticals for Psoriasis Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 UCB
  26. 6.5.1 UCB Company Information
  27. 6.5.2 UCB Business Overview
  28. 6.5.3 UCB Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 UCB Biopharmaceuticals for Psoriasis Product Portfolio
  30. 6.5.5 UCB Recent Developments
  31. 6.6 Organon
  32. 6.6.1 Organon Company Information
  33. 6.6.2 Organon Business Overview
  34. 6.6.3 Organon Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Organon Biopharmaceuticals for Psoriasis Product Portfolio
  36. 6.6.5 Organon Recent Developments
  37. 6.7 Amgen
  38. 6.7.1 Amgen Company Information
  39. 6.7.2 Amgen Business Overview
  40. 6.7.3 Amgen Biopharmaceuticals for Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Amgen Biopharmaceuticals for Psoriasis Product Portfolio
  42. 6.7.5 Amgen Recent Developments
7 North America by Country
  1. 7.1 North America Biopharmaceuticals for Psoriasis Sales by Country
  2. 7.1.1 North America Biopharmaceuticals for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biopharmaceuticals for Psoriasis Sales by Country (2021-2026)
  4. 7.1.3 North America Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biopharmaceuticals for Psoriasis Market Size by Country
  6. 7.2.1 North America Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026)
  8. 7.2.3 North America Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biopharmaceuticals for Psoriasis Sales by Country
  2. 8.1.1 Europe Biopharmaceuticals for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biopharmaceuticals for Psoriasis Sales by Country (2021-2026)
  4. 8.1.3 Europe Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biopharmaceuticals for Psoriasis Market Size by Country
  6. 8.2.1 Europe Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biopharmaceuticals for Psoriasis Sales by Country
  2. 9.1.1 Asia-Pacific Biopharmaceuticals for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biopharmaceuticals for Psoriasis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biopharmaceuticals for Psoriasis Market Size by Country
  6. 9.2.1 Asia-Pacific Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biopharmaceuticals for Psoriasis Sales by Country
  2. 10.1.1 South America Biopharmaceuticals for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biopharmaceuticals for Psoriasis Sales by Country (2021-2026)
  4. 10.1.3 South America Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biopharmaceuticals for Psoriasis Market Size by Country
  6. 10.2.1 South America Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026)
  8. 10.2.3 South America Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country
  2. 11.1.1 Middle East and Africa Biopharmaceuticals for Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biopharmaceuticals for Psoriasis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biopharmaceuticals for Psoriasis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biopharmaceuticals for Psoriasis Market Size by Country
  6. 11.2.1 Middle East and Africa Biopharmaceuticals for Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biopharmaceuticals for Psoriasis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biopharmaceuticals for Psoriasis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biopharmaceuticals for Psoriasis Value Chain Analysis
  2. 12.1.1 Biopharmaceuticals for Psoriasis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biopharmaceuticals for Psoriasis Production Mode & Process
  7. 12.2 Biopharmaceuticals for Psoriasis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biopharmaceuticals for Psoriasis Distributors
  10. 12.2.3 Biopharmaceuticals for Psoriasis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst